Publicacións nas que colabora con María Pardo Pérez (22)

2023

  1. Downregulated Adipose Tissue Expression of Browning Genes With Increased Environmental Temperatures

    The Journal of clinical endocrinology and metabolism, Vol. 109, Núm. 1, pp. e145-e154

  2. Extracellular Vesicles and Their Renin–Angiotensin Cargo as a Link between Metabolic Syndrome and Parkinson’s Disease

    Antioxidants, Vol. 12, Núm. 12

2022

  1. Platelet Lipidome Fingerprint: New Assistance to Characterize Platelet Dysfunction in Obesity

    International Journal of Molecular Sciences, Vol. 23, Núm. 15

2021

  1. Phosphoproteomic Analysis of Platelets in Severe Obesity Uncovers Platelet Reactivity and Signaling Pathways Alterations

    Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 41, Núm. 1, pp. 478-490

  2. Role of somatic mutations and chromosomal aberrations in the prognosis of uveal melanoma in a Spanish patient cohort

    Acta Ophthalmologica, Vol. 99, Núm. 7, pp. e1077-e1089

2020

  1. Analysis of platelets from a diet-induced obesity rat model: elucidating platelet dysfunction in obesity

    Scientific Reports, Vol. 10, Núm. 1

2019

  1. A Combination of Proteomic Approaches Identifies A Panel of Circulating Extracellular Vesicle Proteins Related to the Risk of Suffering Cardiovascular Disease in Obese Patients

    Proteomics, Vol. 19, Núm. 1-2

  2. Data on hyper-activation of GPVI signalling in obese patients: Towards the identification of novel antiplatelet targets in obesity

    Data in Brief

  3. GPVI surface expression and signalling pathway activation are increased in platelets from obese patients: Elucidating potential anti-atherothrombotic targets in obesity

    Atherosclerosis, Vol. 281, pp. 62-70

2017

  1. In vivo eye surface residence determination by high-resolution scintigraphy of a novel ion-sensitive hydrogel based on gellan gum and kappa-carrageenan

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 114, pp. 317-323

  2. Positron emission tomography for the development and characterization of corneal permanence of ophthalmic pharmaceutical formulations

    Investigative Ophthalmology and Visual Science, Vol. 58, Núm. 2, pp. 772-780

2015

  1. Serum dipeptidyl peptidase IV activity and sCD26 concentration in patients with choroidal nevus or uveal melanoma

    Clinica Chimica Acta

2013

  1. The gastric CB1 receptor modulates ghrelin production through the mTOR pathway to regulate food intake

    PLoS ONE, Vol. 8, Núm. 11

2012

  1. III Jornadas Bienales de Jóvenes Investigadores en Proteómica, Santiago de Compostela 2012: una visión de futuro y optimismo ante un horizonte incierto

    Proteómica: revista de la Sociedad Española de Proteómica, Núm. 8, pp. 13-14

2011

  1. The SHP-1 protein tyrosine phosphatase negatively modulates Akt signaling in the ghrelin/GHSR1a system

    Molecular Biology of the Cell, Vol. 22, Núm. 21, pp. 4182-4191

  2. The vagus nerve as a regulator of growth hormone secretion

    Regulatory Peptides, Vol. 166, Núm. 1-3, pp. 3-8

2010

  1. Age, sex, and lactating status regulate ghrelin secretion and GOAT mRNA levels from isolated rat stomach

    American Journal of Physiology - Endocrinology and Metabolism, Vol. 299, Núm. 3

2007

  1. Biomarker discovery from uveal melanoma secretomes: Identification of gp100 and cathepsin D in patient serum

    Journal of Proteome Research, Vol. 6, Núm. 7, pp. 2802-2811

2006

  1. The characterization of the invasion phenotype of uveal melanoma tumour cells shows the presence of MUC18 and HMG-1 metastasis markers and leads to the identification of DJ-1 as a potential serum biomarker

    International Journal of Cancer, Vol. 119, Núm. 5, pp. 1014-1022

2005

  1. Proteome analysis of a human uveal melanoma primary cell culture by 2-DE and MS

    Proteomics, Vol. 5, Núm. 18, pp. 4980-4993